News about 'Announcements'

14 Aug 2012
We invite you to join us for the Stop TB Partnership Working Group on New Drugs’ 2012 Annual Meeting at the Impiana KLCC Hotel in Kuala Lumpur, Malaysia on Wednesday, November 14. Also, we are sponsoring a lunch to allow the Sub-groups (Biology/Targets, Candidates, Critical Knowledge and Tools, and...
31 Jul 2012
Press Release: The Africa Coalition on Tuberculosis (ACT!), whose inception was the result of a Declaration made in Washington, DC, USA in March 2012, kicked off activities at a week-long planning meeting in June in Tirano, Italy. Founding members of the coalition include tuberculosis (TB)...
23 Jul 2012
Yesterday, efficacy data from the first novel regimen trial (NC001) were published in the Lancet . The results found that the regimen containing PA-824, moxifloxacin, and pyrazinamide, could kill more than 99 percent of patients’ TB bacteria within two weeks and could be more effective than...
22 Jul 2012
TB REACH, an initiative of the Stop TB Partnership to promote early and increased TB case detection, today has launched its call for applications for Wave 3 funding. Partners of the Stop TB Partnership, national TB programmes, HIV programmes, local and international NGOs, civil society and...
4 Jul 2012
Structure of Bedaquiline This week it was announced the Janssen Pharmaceuticals, Inc., a pharmaceutical company of Johnson & Johnson, filed a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) for their drug Bedaquiline (a.k.a. TMC-207). For additional information on...
13 Jun 2012
The Stop TB Partnership made two exciting announcements today: 1. US$ 40 million committed to roll-out of Xpert The executive board of UNITAID today approved funding of US$ 30 million to scale up access to Xpert MTB/RIF, and reduce the cost of its use. In addition, the Stop TB Partnership’s TB...
6 Jun 2012
Delamanid (OPC-67683) This week, efficacy data from the recently completed Phase 2 randomized placebo-controlled trial in MDR patients evaluating delamanid with background treatment compared to placebo with background treatment was published yesterday in the New England Journal of Medicine ...
30 Apr 2012
World TB Day Congressional Briefing Tuberculosis – We Can Beat this Global Killer Wednesday, March 21, 2012 A briefing and update on tuberculosis (TB), a disease that is curable but still takes the lives of 4,000 people each day and is the number one killer of people living with HIV. Special areas...
30 Apr 2012
The latest news from the Stop TB Partnership. You may also download a .pdf version by clicking here . WORLD TB DAY NEWS Childhood tuberculosis neglected, despite available remedies TB often goes undiagnosed in children because they lack access to care, or because health workers don’t recognize the...
28 Mar 2012
Click here to access publication. The WGND Strategic Plan 2011-2015 is an update of the “New Drugs” section of the Global Plan to Stop TB: 2011-2015 . It describes the progress, gaps, and vision of the WGND and the TB drug development field as a whole. Since its inception, the WGND has served as a...
23 Mar 2012
Announcing the InnovateTB contest! Innovations are revolutionizing TB. Tell us your story! On World TB Day, the Stop TB Partnership Working Group on New TB Drugs (WGND) announces the InnovateTB Contest to encourage and highlight innovations to achieve zero deaths from TB in this generation. We are...
22 Mar 2012
Click here to get more info. Saturday, March 24, is officially World TB Day but there has been a stream of activities, publications, news and messages to let the world not forget about this major infectious disease killer that claims millions of lives each year. Events On March 7 and 13, the CORE...
20 Mar 2012
The audience takes in the promise of the NC--002 trial. During the “Cure All: A briefing on the status of the most promising new TB drugs research” sponsored by the Critical Path to New TB Drug Regimens (CPTR) on Monday, March 19, Dr. Mel Spigelman, CEO & President, of TB Alliance announced the...
5 Mar 2012
U.S. Representative Donald Payne (D-NJ) Statement from RESULTS: RESULTS Mourns the Death of Rep. Donald Payne Joanne Carter, Executive Director of RESULTS/RESULTS Educational Fund, issued the following statement: RESULTS is saddened to learn of the death of Representative Donald Payne, who was a...
13 Feb 2012
Click here to go to the Global Health Trials website. We would like to share an exciting development in the field of global health, which has been launched in the last six months – an innovative professional membership scheme for tracking the continued professional development of clinical research...

Pages